CRTX (CRTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 85 253 sessions, July 29, 2021 to July 29, 2022
- Largest daily move
- -76.6% close of October 27, 2021
- 1-year change
- -96.5% closing prices, July 29, 2021 to July 29, 2022
Company Description
CRTX (Nasdaq: CRTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $70.5M.
CRTX has declined 96.5% over the past year. The last closing price was $1.95.
This page collects what Stock Titan holds for CRTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CRTX (CRTX) closed at $1.95 on July 29, 2022. Over the past 12 months, the price has lost 96.5%.
CRTX Metrics & Rankings
Price returns through July 29, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CRTX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, management, acquisition, conferences. View all CRTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CRTX Company Profile & Sector Positioning
CRTX (CRTX) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CRTX often look at related companies in the same sector, including X4 Pharmaceuticals, Inc. (XFOR), Adicet Bio, Inc. (ACET), OS Therapies Incorporated (OSTX), HTBX (HTBX), and Immix Biopharma, Inc. (IMMX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CRTX's relative position within its industry.